Overestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
Jeffrey Borman, Integrichain, Inc.
Advertisement
Articles by Jeffrey Borman, Integrichain, Inc.
Advertisement
Latest Updated Articles
- Forecasting Returns When Patents Expire
Published: April 8th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
The Key to Connecting with Patients: Pharma's Market Access Transformation
3
CEVA Logistics Expands End-to-End Capabilities With Acquisition of Project Logistics Specialist Fagioli
4
Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access
5